Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
[Anti-NMDA receptor encephalitis - case report].
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis.
Cost analysis of multiple sclerosis in Brazil: a cross-sectional multicenter study.
Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats.
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
Early development of anti-natalizumab antibodies in MS patients.
[Oral disease modifying therapy of multiple sclerosis: the current view.]
Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
Comparing Two Deep Brain Stimulation Leads to One in Refractory Tremor.
[Optic neuritis: diagnosis, treatment and clinical implications].
Screening for MOG-IgG and 27 other anti-glial and anti-neuronal autoantibodies in 'pattern II multiple sclerosis' and brain biopsy findings in a MOG-IgG-positive case.
Phase IIa laquinimod trial results show positive data for potential use in active Crohn's disease
Assessing interactions between HLA-DRB1*15 and infectious mononucleosis on the risk of multiple sclerosis.
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
Effect of natalizumab on oxidative damage biomarkers in relapsing-remitting multiple sclerosis.
Pre-existing T- and B-cell defects in one progressive multifocal leukoencephalopathy patient.
Influence of yoga and aerobics exercise on fatigue, pain and psychosocial status in patients with multiple sclerosis: A Randomized Trial.
Experimental RRMS Therapy to Be Tested in a Phase 2b Clinical Trial
Use of Complementary and Alternative Medicine among People with Multiple Sclerosis in the Nordic Countries.
Riluzole enhances the anti-seizure action of conventional antiepileptic drugs against pentetrazole-induced convulsions in mice.
Overlapping demyelinating syndromes and anti-NMDA receptor encephalitis.
7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study.
Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation.
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
Pages
« first
‹ previous
…
184
185
186
187
188
189
190
191
192
…
next ›
last »